These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

512 related articles for article (PubMed ID: 12698071)

  • 41. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A practical approach to achieving recommended blood pressure goals in diabetic patients.
    Bakris GL
    Arch Intern Med; 2001 Dec 10-24; 161(22):2661-7. PubMed ID: 11732930
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Blood pressure in renal disease: how to accomplish the goal?
    Robles NR; Hernandez-Gallego R
    Cardiovasc Ther; 2012 Aug; 30(4):193-8. PubMed ID: 22759229
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Nephro-protection: role of arterial pressure in progression of renal pathology. Does a nephro-protective effect depend on the choice of antihypertensive drug?].
    Shestakova MV
    Ter Arkh; 2001; 73(6):64-6. PubMed ID: 11521527
    [No Abstract]   [Full Text] [Related]  

  • 45. Antihypertensive therapy. Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and calcium antagonists.
    Gifford RW
    Med Clin North Am; 1997 Nov; 81(6):1319-33. PubMed ID: 9356601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diabetes mellitus and hypertension: a mandate for intense treatment according to new guidelines.
    Prisant LM
    Am J Ther; 2003; 10(5):363-9. PubMed ID: 12975721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Controversies surrounding the treatment of the hypertensive patient with diabetes.
    Prisant LM; Louard RJ
    Curr Hypertens Rep; 1999 Dec; 1(6):512-20. PubMed ID: 10981115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial): primary antihypertensive agents - diuretics vs calcium channel blockers vs angiotensin-converting enzyme inhibitors].
    Scholze J; Unger T
    Internist (Berl); 2003 Sep; 44(9):1193-5. PubMed ID: 14566471
    [No Abstract]   [Full Text] [Related]  

  • 49. Relative efficacy of, and some adverse reactions to, different antihypertensive regimens.
    Moser M
    Am J Cardiol; 1989 Jan; 63(4):2B-7B. PubMed ID: 2563187
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.
    Turnbull F;
    Lancet; 2003 Nov; 362(9395):1527-35. PubMed ID: 14615107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacologic management of diabetic nephropathy.
    Vivian EM; Rubinstein GB
    Clin Ther; 2002 Nov; 24(11):1741-56; discussion 1719. PubMed ID: 12501871
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of beta-blockade and angiotensin converting enzyme inhibition on kidney function in diabetic nephropathy.
    Hommel E
    J Hypertens Suppl; 1989 Sep; 7(7):S49-51. PubMed ID: 2575661
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination therapy in hypertension.
    Gorostidi M; de la Sierra A
    Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Calcium antagonists and the diabetic patient: a response to recent controversies.
    Poulter NR
    Am J Cardiol; 1998 Nov; 82(9B):40R-41R. PubMed ID: 9822144
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Protective effect of antihypertensive agents on renal insufficiency (REIN, RENAAL, IDNT, AASK, etc)].
    Tsuchida H; Kimura K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():617-22. PubMed ID: 15171445
    [No Abstract]   [Full Text] [Related]  

  • 57. The value of irbesartan in the management of hypertension.
    Bramlage P; Durand-Zaleski I; Desai N; Pirk O; Hacker C
    Expert Opin Pharmacother; 2009 Aug; 10(11):1817-31. PubMed ID: 19601700
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.